← Back to Newsletter Archive
Greetings!

Welcome to the Monthly QPS Clinical Newsletter


Streamline your clinical trials with QPS Central Safety Laboratories, advance your weight loss studies with QPS Clinical Research Operations, and catch up on the latest science news on the QPS Blog.



QPS Full Service Central Safety Labs

The QPS Central Safety Labs prepare and ship collection kits, analyze samples, and deliver regulatory-compliant reports, managing every detail to keep clinical trial testing on track.


With clinical trial kit logistics and safety sample testing coordinated, your team can spend less time coordinating details and more time focused on the trial.

Talk with a Central Safety Labs Expert Today

Advancing Weight Loss Research with QPS

The right participants, a well-run clinical trial and reliable data can help you make the best study decisions. QPS combines complex obesity clinical trial experts with specialized bioanalysis and clinical research operations spanning Phase I through Phase IV.


Our dedicated early phase units and global site network help you recruit participants and answer critical drug development questions.


Explore the science shaping obesity drug research in this white paper, The Frontiers of Obesity Treatment.

Discover the Future of Science on the QPS Blog

A Growing Biosimilar Opportunity Meets a Limited Pipeline



As patents expire on biological drugs over the next decade, opportunities for biosimilar development should be growing. The pipeline tells a different story...


The FDA Seeks to Reduce Development Requirements

White Paper: Biosimilars Accelerated

Exploring the FDA’s Revised Pivotal Trial Guidance


Drug approval has long been associated with two identical pivotal clinical trials demonstrating that not only is the drug safe and effective, but also that the…


Looking Across the Development Program

Global Regulatory Affairs

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

 
Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive